| scholarly article | Q13442814 |
| P50 | author | Kathrin Plath | Q30347917 |
| Bennett G. Novitch | Q42321183 | ||
| Harley I Kornblum | Q114444398 | ||
| P2093 | author name string | Joy A Umbach | |
| Martina Wiedau-Pazos | |||
| Saravanan Karumbayaram | |||
| Michaela Patterson | |||
| Amander T Clark | |||
| Anne E Conway | |||
| Anne Lindgren | |||
| Laura Richter | |||
| William E Lowry | |||
| Steve A Goldman | |||
| P2860 | cites work | Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 |
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Vertebrate neurogenesis is counteracted by Sox1-3 activity | Q28205692 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
| Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 | ||
| Directed differentiation of embryonic stem cells into motor neurons | Q29616200 | ||
| Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
| Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules | Q37254921 | ||
| Marked differences in differentiation propensity among human embryonic stem cell lines | Q40012772 | ||
| Functional properties of motoneurons derived from mouse embryonic stem cells. | Q40517622 | ||
| Early motor neuron pool identity and muscle nerve trajectory defined by postmitotic restrictions in Nkx6.1 activity | Q43089641 | ||
| Specification of motoneurons from human embryonic stem cells. | Q45246951 | ||
| Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells | Q46730802 | ||
| Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. | Q51066733 | ||
| Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. | Q51986995 | ||
| A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. | Q52034963 | ||
| Motor neuron columnar fate imposed by sequential phases of Hox-c activity. | Q52098449 | ||
| Development of ionic currents underlying changes in action potential waveforms in rat spinal motoneurons. | Q52181242 | ||
| Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease | Q73775072 | ||
| Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis | Q79733723 | ||
| P433 | issue | 4 | |
| P921 | main subject | Human Induced Pluripotent Stem Cells | Q88981775 |
| P304 | page(s) | 806-811 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Directed differentiation of human-induced pluripotent stem cells generates active motor neurons | |
| P478 | volume | 27 |
| Q26859884 | "Seq-ing" insights into the epigenetics of neuronal gene regulation |
| Q49168576 | A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids. |
| Q36588788 | AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice |
| Q54964081 | Adherent vs. Free-Floating Neural Induction by Dual SMAD Inhibition for Neurosphere Cultures Derived from Human Induced Pluripotent Stem Cells. |
| Q38332493 | Adult human neural stem cell therapeutics: Current developmental status and prospect |
| Q90396913 | Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis |
| Q44704967 | Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis |
| Q37000469 | An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. |
| Q39356795 | An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background |
| Q35071401 | Annual Research Review: The promise of stem cell research for neuropsychiatric disorders |
| Q92556132 | Application of chemical reaction engineering principles to 'body-on-a-chip' systems |
| Q37742101 | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies |
| Q21133511 | Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue |
| Q33684338 | Binary fate decisions in differentiating neurons |
| Q39259312 | Bone tissue engineering of induced pluripotent stem cells cultured with macrochanneled polymer scaffold |
| Q35648117 | Cell therapy for multiple sclerosis |
| Q42363724 | Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern |
| Q34329654 | Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors |
| Q39217787 | Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells |
| Q87175977 | Comparison of different protocols for neural differentiation of human induced pluripotent stem cells |
| Q38021973 | Concise review: human pluripotent stem cells in the treatment of spinal cord injury |
| Q37841398 | Concise review: stem cells for the treatment of cerebellar-related disorders |
| Q33924616 | Converted neural cells: induced to a cure? |
| Q26861926 | Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review |
| Q35958875 | Defining the nature of human pluripotent stem cell progeny |
| Q38906124 | Derivation of motor neuron-like cells from neonatal mouse testis in a simple culture condition. |
| Q50033636 | Deriving Dorsal Spinal Sensory Interneurons from Human Pluripotent Stem Cells |
| Q38752574 | Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. |
| Q48092727 | Differentiation Potential of Human Chorion-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells in Two- and Three-Dimensional Culture Systems. |
| Q28533809 | Differentiation of mouse induced pluripotent stem cells (iPSCs) into nucleus pulposus-like cells in vitro |
| Q45043594 | Differentiation of mouse induced pluripotent stem cells into corneal epithelial-like cells |
| Q37460845 | Differentiation of spinal motor neurons from pluripotent human stem cells |
| Q53397967 | Differentiation potential of human bone marrow mesenchymal stem cells into motorneuron-like cells on electrospun gelatin membrane. |
| Q47970651 | Direct Reprogramming of Human Suspension Cells into Mesodermal Cell Lineages via Combined Magnetic Targeting and Photothermal Stimulation by Magnetic Graphene Oxide Complexes |
| Q37359163 | Direct conversion of adipocyte progenitors into functional neurons |
| Q58612523 | Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons |
| Q64128448 | Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines |
| Q36780691 | Direct reprogramming of human fibroblasts into sweat gland-like cells |
| Q30585778 | Directing human induced pluripotent stem cells into a neurosensory lineage for auditory neuron replacement |
| Q24298254 | Dynamic distribution of linker histone H1.5 in cellular differentiation |
| Q39802426 | Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. |
| Q38034476 | Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology |
| Q36229098 | Engineered HA hydrogel for stem cell transplantation in the brain: Biocompatibility data using a design of experiment approach |
| Q51831198 | Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds. |
| Q34217805 | Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers |
| Q37998983 | Experimental therapies for repair of the central nervous system: stem cells and tissue engineering. |
| Q33989488 | Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells |
| Q34111572 | Female human iPSCs retain an inactive X chromosome |
| Q37293528 | FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells |
| Q37056282 | From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols |
| Q34264572 | Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons |
| Q36458914 | Generation of induced pluripotent stem cells from human Tenon's capsule fibroblasts |
| Q42159813 | Generation of transplantable Beta cells for patient-specific cell therapy |
| Q34234455 | Genetic basis of inherited macular dystrophies and implications for stem cell therapy. |
| Q34437293 | Genomic editing tools to model human diseases with isogenic pluripotent stem cells |
| Q38700229 | Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish |
| Q37684345 | Glial progenitor cell-based treatment of the childhood leukodystrophies |
| Q39166287 | Glioma gene therapy using induced pluripotent stem cell derived neural stem cells |
| Q36930602 | Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks. |
| Q39037865 | High content analysis in amyotrophic lateral sclerosis |
| Q42125464 | Human induced pluripotent stem cells generated neural cells behaving like brain and spinal cord cells: An insight into the involvement of retinoic acid and sonic hedgehog proteins |
| Q37776428 | Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells |
| Q30395748 | Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. |
| Q37950950 | Human pluripotent stem cells for disease modelling and drug screening |
| Q37931912 | Human pluripotent stem cells for genetic disease modeling and drug screening. |
| Q28652313 | Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes |
| Q33788845 | Human stem cells for craniomaxillofacial reconstruction. |
| Q48215211 | Hypergravity stimulation enhances PC12 neuron-like cell differentiation. |
| Q36253650 | Important precautions when deriving patient-specific neural elements from pluripotent cells |
| Q38753758 | In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities |
| Q37745594 | In vitro regeneration of kidney from pluripotent stem cells |
| Q37592612 | Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury |
| Q34031081 | Induced Pluripotent Stem Cells-A New Foundation in Medicine |
| Q38014843 | Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine |
| Q38107885 | Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases |
| Q37800367 | Induced pluripotent stem (iPS) cells: an up-to-the-minute review |
| Q26823333 | Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease |
| Q37641699 | Induced pluripotent stem cell therapies for retinal disease |
| Q39830573 | Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures |
| Q38358569 | Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine |
| Q38218254 | Induced pluripotent stem cells for regenerative medicine |
| Q38026488 | Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective |
| Q35840653 | Induced pluripotent stem cells in the study of neurological diseases |
| Q37779822 | Induced pluripotent stem cells--alchemist's tale or clinical reality? |
| Q34923975 | Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders |
| Q37801268 | Induced pluripotent stem cells: developmental biology to regenerative medicine |
| Q30420062 | Inducible pluripotent stem cells: not quite ready for prime time? |
| Q42483604 | Induction of putative stratified epithelial progenitor cells in vitro from mouse-induced pluripotent stem cells. |
| Q34314191 | Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy |
| Q39189306 | Insights into cell-free therapeutic approach: Role of stem cell "soup-ernatant". |
| Q37982705 | Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies. |
| Q35130996 | Investigation of hepatoprotective activity of induced pluripotent stem cells in the mouse model of liver injury. |
| Q27319853 | Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells |
| Q35540393 | Model systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents |
| Q93038643 | Modeling genetic epilepsies in a dish |
| Q34749749 | Motoneuron differentiation of induced pluripotent stem cells from SOD1G93A mice |
| Q35473397 | Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons |
| Q26822886 | Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives |
| Q39148891 | Motor neuron differentiation from pluripotent stem cells and other intermediate proliferative precursors that can be discriminated by lineage specific reporters |
| Q34470920 | Moving stem cells to the clinic: potential and limitations for brain repair |
| Q47283219 | Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges |
| Q28551899 | Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells |
| Q34599726 | Nanofiber matrices promote the neuronal differentiation of human embryonic stem cell-derived neural precursors in vitro. |
| Q28648114 | Neural Commitment of Embryonic Stem Cells through the Formation of Embryoid Bodies (EBs) |
| Q33732735 | Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency |
| Q40884175 | Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis |
| Q46524989 | Neuronal Cell Sheets of Cortical Motor Neuron Phenotype Derived from Human iPSCs |
| Q36945734 | New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells |
| Q38121637 | New therapy options for amyotrophic lateral sclerosis |
| Q39094722 | Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks |
| Q36607409 | Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo |
| Q34619318 | Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells |
| Q58785850 | On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations |
| Q37893537 | PET molecular imaging in stem cell therapy for neurological diseases |
| Q37620711 | PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons. |
| Q42205262 | Patch clamp apply in cardiomyocytes derived from patient's iPS cells for individual anticancer therapy. |
| Q41836711 | Patient-specific pluripotent stem cells in neurological diseases |
| Q47872679 | Polysaccharide nanofibers with variable compliance for directing cell fate |
| Q54403275 | Potential of Induced Pluripotent Stem Cells for the Regeneration of the Tracheal Wall |
| Q38010704 | Preclinical models to investigate retinal ischemia: advances and drawbacks |
| Q39684952 | Programmatic change: lung disease research in the era of induced pluripotency |
| Q37697617 | Progress and promise towards safe induced pluripotent stem cells for therapy |
| Q38795457 | Protein regulation of induced pluripotent stem cells by transplanting in a Huntington's animal model |
| Q33937536 | Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen |
| Q48018020 | Protocol for Directed Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) to a Hepatic Lineage |
| Q27335011 | Purification of immature neuronal cells from neural stem cell progeny |
| Q38017202 | Recent developments in transposon-mediated gene therapy |
| Q37809803 | Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010 |
| Q93046793 | Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells |
| Q89811163 | Small-molecule-mediated reprogramming: a silver lining for regenerative medicine |
| Q39309888 | Sourcing and using stem cell lines for radiation research: Potential, challenges and good stem cell culture practice |
| Q37976119 | Standardization of pluripotent stem cell cultures for toxicity testing |
| Q52619084 | Stem Cells Therapy for Spinal Cord Injury. |
| Q57345687 | Stem Cells, Bioengineering, and 3-D Scaffolds for Nervous System Repair and Regeneration |
| Q37643268 | Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking |
| Q36301821 | Stem cell therapy for amyotrophic lateral sclerosis |
| Q34129832 | Stem cell therapy for cerebral ischemia: from basic science to clinical applications |
| Q35087066 | Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease |
| Q37747349 | Stem cells in genetic myelin disorders |
| Q27687068 | Stem cells in human neurodegenerative disorders--time for clinical translation? |
| Q34845881 | Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells |
| Q39000555 | Substantial Differentiation of Human Neural Stem Cells Into Motor Neurons on a Biomimetic Polyurea |
| Q41634284 | Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain |
| Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
| Q58086434 | Systems-Wide Approaches in Induced Pluripotent Stem Cell Models |
| Q33788869 | Tbx1 modulates endodermal and mesodermal differentiation from mouse induced pluripotent stem cells |
| Q55437504 | The Efficacy of Graphene Foams for Culturing Mesenchymal Stem Cells and Their Differentiation into Dopaminergic Neurons. |
| Q58883595 | The Efficient Generation of Induced Pluripotent Stem (iPS) Cells from Adult Mouse Adipose Tissue-Derived and Neural Stem Cells |
| Q26860309 | The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges |
| Q38559610 | The State of Play with iPSCs and Spinal Cord Injury Models. |
| Q37980016 | The emerging role of stem cells in ocular neurodegeneration: hype or hope? |
| Q35981667 | The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk |
| Q37856714 | The use of induced pluripotent stem cells in drug development |
| Q89166348 | Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons |
| Q35805656 | Transdifferentiation of Fibroblasts by Defined Factors |
| Q37772899 | Translational prospects for human induced pluripotent stem cells |
| Q37729046 | Transplantation of Embryonic Spinal Cord Derived Cells Helps to Prevent Muscle Atrophy after Peripheral Nerve Injury. |
| Q42408065 | Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons |
| Q84796896 | Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia |
| Q38065343 | Understanding ALS: new therapeutic approaches. |
| Q38399817 | Uniform-sized neurosphere-mediated motoneuron differentiation in microwell arrays. |
| Q38371445 | Use of stem cells for liver diseases-current scenario. |
| Q26796332 | Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies |
| Q34745357 | Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice |
| Q34714347 | What can pluripotent stem cells teach us about neurodegenerative diseases? |
| Q37131089 | Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research? |
| Q89618057 | [Effect of the local application of stem cells on repairing facial nerve defects: a systematic review] |
| Q48598887 | iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats |
| Q26765886 | iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System |
| Q34530170 | let-7 miRNAs can act through notch to regulate human gliogenesis |
Search more.